Narrative review / 2013
A review indicates that the synthetic sweetener sucralose is not biologically inert and can alter metabolic, gut, and chemical endpoints.
This review summarizes biological issues associated with the synthetic sweetener sucralose. Findings show that sucralose interacts with alimentary chemosensors and, in both human and rodent studies, may alter glucose, insulin, and glucagon-like peptide 1 (GLP-1) levels. Animal studies demonstrate increased intestinal expression of P-gp and two CYP isozymes, altered gut microbial composition, and evidence of gastrointestinal metabolism into unidentified metabolites. Additionally, sucralose and a hydrolysis product were mutagenic at elevated concentrations in several tests, and cooking at high temperatures generated potentially toxic chloropropanols.
- Study type
- Narrative review
- Who was studied
- Human and rodent studies
- What was measured
- Biological effects of sucralose, including gut microbiota, drug metabolism, metabolism, mutagenicity, and thermal degradation
THE PAPER
Sucralose, a synthetic organochlorine sweetener: overview of biological issues.
Schiffman SS, Rother KI. J Toxicol Environ Health B Crit Rev, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.